Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 1
Research Paper
Optimization and qualification of an assay that demonstrates that a FimH vaccine induces functional antibody responses in women with histories of urinary tract infections
Courtney M. Starksa Sequoia Sciences, Inc., 1912 Innerbelt Business Center Drive, St. Louis, MO, USACorrespondence[email protected]
https://orcid.org/0000-0002-2503-8203View further author information
https://orcid.org/0000-0002-2503-8203View further author information, , Peter M. Broglieb BioAgilytix Labs, LLC, Durham, NC, USAhttps://orcid.org/0000-0003-2891-6275View further author information
https://orcid.org/0000-0003-2891-6275View further author information, Joshua Cubbisonb BioAgilytix Labs, LLC, Durham, NC, USAhttps://orcid.org/0000-0001-6585-7505View further author information
https://orcid.org/0000-0001-6585-7505View further author information, Steven M. Martina Sequoia Sciences, Inc., 1912 Innerbelt Business Center Drive, St. Louis, MO, USAhttps://orcid.org/0000-0002-7832-1088View further author information
https://orcid.org/0000-0002-7832-1088View further author information & 